(A) Established B16 S.C. tumors were dissociated and analyzed for NKG2D ligand expression on tumor-associated macrophages. (B) RAE-1δ expression (left) and MFI quantification (right) on the …
(A) Gating strategy to identify tumor-associated macrophages in B16 tumors. (B) Expression of RAE-1δ on TAMs in B16 S.C. tumors in WT and RAE-1-KO mice. (C) RAE-1δ expression on TAMs, splenic …
(A) B16 cells transduced to stably express RAE-1δ or RAE-1ε were stained with biotinylated antibodies against RAE-1δ or RAE-1ε, followed by fluorophore-conjugated streptavidin. (B) Expression of …
Gating strategies for (A) monocytes in B16 tumors, (B) blood monocytes, and (C) peritoneal macrophages.
(A) Peritoneal wash cells were cultured with a 1:1 mixture of fresh medium plus 20X concentrated fresh medium or 20X concentrated B16 cell culture supernatants, and macrophage RAE-1δ was analyzed by …
(A) CSF-R1 expression on peritoneal macrophages ex vivo. (B) RAE-1δ expression on peritoneal macrophages cultured 48 hr with the indicated concentration of CSF-1. (C) RAE-1δ expression on …
(A) The indicated numbers of B16 or RMA-S cells were seeded in 12-well plates, and CSF-1 levels in the supernatants were measured by ELISA 48 hr later. (B) Established B16 or RMA-S tumors were …
(A) CSF-1 concentrations in the indicated cell line culture supernatants. (B) CSF-1 concentrations in B16 tumors or serum of naïve or tumor-bearing mice. Data are representative of 2–3 independent …
(A) Mice with established B16 tumors were injected i.p. with 200 ug of the indicated antibody, and RAE-1δ on TAMs was analyzed 48 hr later. (B) KP mice with established sarcomas were injected i.p. …
(A) RAE-1δ on TAMs in B16 tumors from mice given control Ig or anti-CSF-1R at days −1, 2, and 5 and harvested at the indicated time point. (B) TAMs as a percent of total live cells in B16 tumors …
(A) RAE-1δ expression on TAMs in established B16 or B16-Csf1-KO tumors. (B) RAE-1δ on TAMs in mice with established B16 tumors or tumors of a second clone of B16-Csf1-KO cells. (C) RAE-1δ on TAMs in …
(A) Peritoneal wash cells were stimulated with CSF-1 plus vehicle control or PI3Kα inhibitors at 3 μM, and macrophage RAE-1δ was analyzed at 24 hr. (B). Relative macrophage RAE-1δ MFI 24 hr after …
(A) Phospho-S6 staining (top) and MFI quantification (bottom) in macrophages stimulated with control medium or 10 ng/ml CSF-1 for the indicated times. Data are representative of 3 independent …
(A) Peritoneal macrophages from WT or RAE-1-KO mice or were stimulated with 10 ng/ml CSF-1 for 48 hr and then co-cultured with WT splenocytes for 18 hr, and NKG2D levels were analyzed by flow …
(A) TAMs as a percentage of CD45 + cells in established B16 tumors in WT and RAE-1-KO mice. (B) RAE-1δ on TAMs in B16 tumors in WT and NKG2D-KO mice.
Volumes were analyzed at day of harvest (day 15).
Treatment | Macrophage RAE-1δ induction? |
---|---|
IL-1α | |
IL-1β | |
IL-4 | |
IL-6 | |
IL-12 | |
IFNβ | |
IFNγ | |
TNFα | |
CSF1 |